Double maintains 1 strategies that include CBLL - Ceribell, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|
Name | Correlation | AUM | Expense Ratio |
---|
Name | Correlation | AUM | Expense Ratio |
---|
Name | Correlation | AUM | Expense Ratio |
---|
Current Value
$14.811 Year Return
Current Value
$14.811 Year Return
Yahoo
SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming Canaccord Genuity 45th Annual Growth Conference. The presentation will take place on Tuesday, August 12, 2025, at 11:00 a.m. Pacific Standard Time / 2:00 p.m. Eastern Standard Time. E
Yahoo
(Bloomberg) -- Medical-technology companies are helping revive initial public offerings in the life-sciences sector in the US after a tough year so far, during which regulatory uncertainty has hampered such activity.Most Read from BloombergThe World’s Data Center Capital Has Residents SurroundedAn Abandoned Art-Deco Landmark in Buffalo Awaits RevivalBudapest’s Most Historic Site Gets a Controversial RebuildSan Francisco in Talks With Vanderbilt for Downtown CampusBoston’s Dumpsters Overflow as T
Yahoo
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the second quarter of 2025 after the close of trading on Tuesday, August 5, 2025. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on August 5,
Yahoo
Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) TechnologySUNNYVALE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a leading medical technology company transforming the diagnosis and management of patients with serious neurological conditions, announced today that it filed complaints against Natus Medical Incorporated and related subsidiaries (“Natus”), alleging patent infringement and unfair competition. A c
Finnhub
CeriBell Inc:Ceribell Inc - files complaints against Natus for patent infringementCeribell Inc - claims Natus infringes six patents on EEG headband & electrode design...
Finnhub
CeriBell, Inc. dropped from Russell 3000 Value Index...